Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
91-105 of 361
Impacts of Multidisciplinary Tumor Boards and Surgery Integration on NSCLC Survival
Project Oncology®Impacts of Multidisciplinary Tumor Boards and Surgery Integration on NSCLC Survival
AAT C-Terminal Peptides Show Independent Prognostic Value in Early-Stage NSCLC
Project Oncology®AAT C-Terminal Peptides Show Independent Prognostic Value in Early-Stage NSCLC
Early Liquid Biopsy in Advanced Lung Cancer: Real-World Data Suggest Targeted Gains
Project Oncology®Early Liquid Biopsy in Advanced Lung Cancer: Real-World Data Suggest Targeted Gains
Advances in Disease-Modifying and Curative Therapies for Sickle Cell Disease
Project Oncology®Advances in Disease-Modifying and Curative Therapies for Sickle Cell Disease
Alexis Leonard
CRISPR in Sickle Cell: Transforming Care Through Gene Editing
Project Oncology®CRISPR in Sickle Cell: Transforming Care Through Gene Editing
Alexis Leonard
Evaluating Gene Therapy for Sickle Cell Disease: Advantages and Barriers
Project Oncology®Evaluating Gene Therapy for Sickle Cell Disease: Advantages and Barriers
David Jacobsohn
- advertisement
Curative Strategies for Sickle Cell Disease: The Future of Gene Editing
Project Oncology®Curative Strategies for Sickle Cell Disease: The Future of Gene Editing
Alexis Leonard
Crizanlizumab’s Role in Reducing Vaso-Occlusive Crises and Opioid Use in SCD
Project Oncology®Crizanlizumab’s Role in Reducing Vaso-Occlusive Crises and Opioid Use in SCD
Evaluating Digital CBT for Sickle Cell Disease: Insights From the CaRISMA Trial
Project Oncology®Evaluating Digital CBT for Sickle Cell Disease: Insights From the CaRISMA Trial
Advances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role
Project Oncology®Advances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role
Charles Turck, PharmD, BCPS, BCCCP
Jonathon B. Cohen, MD, MS
Examining Barriers and Facilitators in Pediatric Sickle Cell Disease Care
Project Oncology®Examining Barriers and Facilitators in Pediatric Sickle Cell Disease Care
Ashley Baker, MSN, PMHNP
Alyssa Schlenz
Shannon Phillps
Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
Project Oncology®Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
Hallie Blevins, PhD
- advertisement
Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
Project Oncology®Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
Ryan Quigley
Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
Project Oncology®Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
Marlene Mimi Maeusli, PhD.
Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
Project Oncology®Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
Paola Marignani, PhD, EMBA
